JONATHAN ASPINWALL: Open Payments
NPI 1063804722 · CRESTVIEW, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,040 in 57 payments from 21 companies in 2025. Trend: 2023 $1,540 · 2024 $1,315 · 2025 $1,040
Food & beverage: $1,040
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $172 |
| PFIZER INC. | 5 | $99 |
| Dexcom, Inc. | 3 | $94 |
| ABBVIE INC. | 4 | $80 |
| Biosense Webster, Inc. | 2 | $72 |
| Amgen Inc. | 4 | $65 |
| Axsome Therapeutics, Inc. | 3 | $65 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $64 |
| Exact Sciences Corporation | 3 | $44 |
| Novartis Pharmaceuticals Corporation | 3 | $44 |
Products named: Ozempic, Dexcom G6 Transmitter, NURTEC ODT, CARTO 3, Rybelsus, XIFAXAN, OTEZLA, QULIPTA.
Industry payments across FL — which companies pay providers there.
